Tom Snelling

4.3k total citations
160 papers, 2.5k citations indexed

About

Tom Snelling is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tom Snelling has authored 160 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Epidemiology, 47 papers in Infectious Diseases and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tom Snelling's work include Respiratory viral infections research (35 papers), Pneumonia and Respiratory Infections (30 papers) and Influenza Virus Research Studies (28 papers). Tom Snelling is often cited by papers focused on Respiratory viral infections research (35 papers), Pneumonia and Respiratory Infections (30 papers) and Influenza Virus Research Studies (28 papers). Tom Snelling collaborates with scholars based in Australia, United Kingdom and United States. Tom Snelling's co-authors include Peter McIntyre, Kristine Macartney, Adam Jaffé, Jonathan R. Carapetis, Christopher C. Blyth, Helen Quinn, Peter Richmond, Ross Andrews, Nusrat Homaira and William D. Rawlinson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Tom Snelling

153 papers receiving 2.4k citations

Peers

Countries citing papers authored by Tom Snelling

Since Specialization

Citations

This map shows the geographic impact of Tom Snelling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Snelling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Snelling more than expected).

Fields of papers citing papers by Tom Snelling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Snelling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Snelling. The network helps show where Tom Snelling may publish in the future.

Co-authorship network of co-authors of Tom Snelling

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Snelling. A scholar is included among the top collaborators of Tom Snelling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Snelling. Tom Snelling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	What is the quality of evidence informing vaccine clinical practice recommendations in Australia? 2025 ·Vaccine ·(unknown), Julie Marsh, Kevin Murray, Tom Snelling	0
2	Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial 2024 ·PLoS Medicine ·(unknown), Marie J. Estcourt, (unknown), Julie Marsh, Kirsten P. Perrett, Dianne E. Campbell, Nicholas Wood, Michael R. Gold, Claire S. Waddington, (unknown), (unknown), Nigel Curtis, Mark Jones, Peter McIntyre, Patrick G. Holt, Peter Richmond, Tom Snelling	2
3	Randomised controlled trial of perinatal vitamin D supplementation to prevent early-onset acute respiratory infections among Australian First Nations children: the ‘D-Kids’ study protocol 2023 ·BMJ Open Respiratory Research ·Michael Binks, (unknown), Susan J. Pizzutto, (unknown), (unknown), Jane Nelson, Adrienne Kirby, Peter S Morris, David Simón, Kim Mulholland, (unknown), Amanda Leach, (unknown), Paul V. Licciardi, Tom Snelling, Anne B. Chang	6
4	Predicting the causative pathogen among children with pneumonia using a causal Bayesian network 2023 ·PLoS Computational Biology ·Yue Wu, Steven Mascaro, Mejbah Bhuiyan, Parveen Fathima, (unknown), Mark P. Nicol, Peter Richmond, Lea‐Ann S. Kirkham, (unknown), David A. Foley, Charlie McLeod, Meredith L Borland, Andrew C. Martin, Phoebe Williams, Julie Marsh, Tom Snelling, Christopher C. Blyth	5
5	Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical Trial 2022 ·The Journal of Infectious Diseases ·(unknown), Margie Danchin, Mark Jones, Amanda Leach, Nigel A. Cunliffe, Carl D. Kirkwood, Jonathan R. Carapetis, (unknown), Lea‐Ann S. Kirkham, (unknown), Monica McNeal, Julie Marsh, Claire S. Waddington, Tom Snelling	5
6	Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial 2022 ·BMJ Open ·Ameneh Khatami, David A. Foley, Morgyn S. Warner, Elizabeth H Barnes, Anton Y. Peleg, Jian Li, Stephen M. Stick, (unknown), Ruby C.Y. Lin, (unknown), Tom Snelling, Steven Y. C. Tong, Jonathan R. Iredell	41
7	Study protocol for controlled human infection for penicillin G against Streptococcus pyogenes : a double-blinded, placebo-controlled, randomised trial to determine the minimum concentration required to prevent experimental pharyngitis (the CHIPS trial) 2022 ·BMJ Open ·(unknown), Joshua Osowicki, Sam Salman, Kevin T. Batty, Julie Marsh, Joseph Kado, Renae K. Barr, Stephanie Enkel, Tom Snelling, James McCarthy, Andrew C. Steer, Jonathan R. Carapetis, Laurens Manning	6
8	Systematic review of the effect of additional doses of oral rotavirus vaccine on immunogenicity and reduction in diarrhoeal disease among young children 2022 ·EClinicalMedicine ·(unknown), Parveen Fathima, Tom Snelling, Peter J. Morris	8
9	Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial 2022 ·Trials ·James McGree, Carinna Hockham, Sradha Kotwal, (unknown), Abhinav Bassi, Carol A. Pollock, Louise M. Burrell, Tom Snelling, Vivekanand Jha, Meg Jardine, Mark Jones	2
10	Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance 2021 ·BMJ Open ·Anastasia Phillips, Catherine Glover, Alan Leeb, Patrick Cashman, Parveen Fathima, Nigel W. Crawford, Tom Snelling, David N Dürrheim, Kristine Macartney	10
11	OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule 2020 ·BMJ Open ·(unknown), Marie J. Estcourt, (unknown), Dianne E. Campbell, Kirsten P. Perrett, Julie Marsh, Peter Richmond, Nicholas Wood, Michael Gold, Patrick G. Holt, Claire S. Waddington, Tom Snelling	7
12	10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial 2020 ·BMJ Open ·Victor M. Oguoma, (unknown), Kim Mulholland, Mathuram Santosham, Paul J. Torzillo, Peter McIntyre, Heidi Smith‐Vaughan, Anne Balloch, Mark D. Chatfield, Deborah Lehmann, Michael Binks, Anne B. Chang, Jonathan R. Carapetis, Vicki Krause, Ross Andrews, Tom Snelling, Paul V. Licciardi, Peter Morris, Amanda Leach	3
13	Discrete choice experiment to evaluate preferences of patients with cystic fibrosis among alternative treatment-related health outcomes: a protocol 2019 ·BMJ Open ·Charlie McLeod, Richard Norman, André Schultz, Steven Mascaro, Steve Webb, Tom Snelling	5
14	The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis 2019 ·BMJ Open ·(unknown), Mark Jones, Claire S. Waddington, Margie Danchin, (unknown), Sarah Gallagher, Amanda Leach, Ross Andrews, Carl D. Kirkwood, Nigel A. Cunliffe, Jonathan R. Carapetis, Julie Marsh, Tom Snelling	11
15	‘Links2HealthierBubs’ cohort study: protocol for a record linkage study on the safety, uptake and effectiveness of influenza and pertussis vaccines among pregnant Australian women 2019 ·BMJ Open ·Mohinder Sarna, Ross Andrews, Hannah C. Moore, Michael Binks, Lisa McHugh, Gavin Pereira, Christopher C. Blyth, Paul Van Buynder, Karin Lust, Paul V. Effler, Stephen B. Lambert, Saad B Omer, Donna B Mak, Tom Snelling, (unknown), Peter McIntyre, Nicholas de Klerk, (unknown), Annette K. Regan	13
16	The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children 2018 ·BMJ Open ·Claire S. Waddington, Charlie McLeod, Peter S Morris, Asha C Bowen, Mark Naunton, Jonathan R. Carapetis, Keith Grimwood, Roy M. Robins‐Browne, Carl D. Kirkwood, Rob Baird, David Green, Ross Andrews, (unknown), Joshua Francis, Julie Marsh, Tom Snelling	15
17	Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia 2018 ·BMJ Open ·Alexis Pillsbury, Catherine Glover, Peter Jacoby, Helen Quinn, Parveen Fathima, Patrick Cashman, Alan Leeb, Christopher C. Blyth, Michael Gold, Tom Snelling, Kristine Macartney	37
18	Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort study 2018 ·Vaccine ·Hannah C. Moore, Parveen Fathima, Heather F. Gidding, Nicholas de Klerk, Bette Liu, Vicky Sheppeard, Paul V. Effler, Tom Snelling, Peter McIntyre, Christopher C. Blyth	29
19	Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case–control study protocol 2018 ·BMJ Open ·Mejbah Bhuiyan, Tom Snelling, Rachel Marceau West, (unknown), Tasmina Rahman, Meredith L Borland, Ruth B. Thornton, Lea‐Ann S. Kirkham, Chisha Sikazwe, Andrew C. Martin, Peter Richmond, David W. Smith, Adam Jaffé, Christopher C. Blyth	21
20	Probabilistic linkage of national immunisation and state-based health records for a cohort of 1.9 million births to evaluate Australia’s childhood immunisation program 2017 ·International Journal for Population Data Science ·Heather F. Gidding, Lisa McCallum, Parveen Fathima, Tom Snelling, Bette Liu, Nicholas de Klerk, Christopher C. Blyth, Vicky Sheppeard, Ross Andrews, Louisa Jorm, Peter McIntyre, Hannah C. Moore	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact